Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: May 19, 2010


Caris Life Sciences announced the promotion of Jonathan Knowles as its new chief scientific officer. Previously Caris' vice chairman, Knowles will retain the responsibilities of that role and assume new ones in taking on the position of chief scientific officer.

In this newly created role, Knowles will oversee the development and commercialization of the company's Carisome platform in cancer testing. Additionally, Knowles will be responsible for globalizing Caris' overall scientific and research capabilities.

Before joining Caris, Knowles was president of group research at Roche and the first chairman of the Board for the Innovative Medicines Initiative, a public-private partnership between the European Commission and 28 pharmaceutical companies focused on disease areas of unmet medical need.

Additionally, Knowles has been awarded a distinguished professorship in personalized healthcare at the Finnish Institute for Molecular Medicine at the University of Helsinki, and has been appointed a visiting chair at the University of Oxford.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.